Groupon GRPN · NASDAQ
$15.75 -3.14% (-$0.51)
Summary
29 / 100 · Bulios Score
What speaks for it
- The price moves less than the market (beta 0.24).
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 5.9% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 19% a year over 5 years. Over the last 3 years it fell by 5.9% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $125.7M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 10.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 18
- Hold 21
- Sell 7
Today's price within the analysts' price targets
The average target of $26 is 65% above today's price. 39% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- International Segment 100%
By region
- North America 77%
- International 23%
International Segment brings in 100% of revenue.
Segments in detail